Skip to content
Open access

The cross-site reproducibility of MRI morphometric phenotypes in psychiatric disorders

Jul 2026 · Nature Neuroscience · Vol 29, pp. 2273 - 2282 · 5 citations · 124 references
Medicine

TL;DR

Evaluating the consistency of brain-wide maps of gray matter volume and cortical thickness differences obtained for each of 59 study sites of five psychiatric disorders indicates that current widespread practices in structural MRI are unlikely to identify robust morphometric phenotypes for psychiatric disorders.

Abstract

Decades of structural magnetic resonance imaging (MRI) studies have documented alterations of gray matter morphometry in psychiatric disorders, but the field has failed to identify any consensus disease phenotypes. Here we examine whether current approaches will ever converge on such phenotypes by evaluating the consistency of brain-wide maps of gray matter volume and cortical thickness differences obtained for each of 59 study sites of five psychiatric disorders (schizophrenia, schizoaffective disorder, autism spectrum disorder, major depressive disorder and bipolar disorder), totaling 2,437 patients and 2,065 controls. We find that cross-site consistency is low (median r ≤ 0.16); markedly reduced compared to Alzheimer’s disease (r = 0.54); unexplained by demographic, clinical or scanner differences; and robust to analytic choices. Using bootstrapping, we observe that consistency may improve for sample sizes ≥200 per group for schizophrenia but that other disorders may require much larger samples. Our findings indicate that current widespread practices in structural MRI are unlikely to identify robust morphometric phenotypes for psychiatric disorders. A large analysis of MRI studies in five psychiatric disorders reveals that maps of brain volume differences in psychiatric illness are rarely reproducible, highlighting the need for alternative approaches to biomarker discovery.

Read PDF

Similar papers

Oct 2026

Stage-dependent gray matter morphological alterations across the clinical spectrum of depressive disorder.

BACKGROUND Previous studies have reported gray matter volume (GMV) deficits in different illness stages of depression; however, whether patients at different stages show shared or distinct GMV abnormality patterns has not been systematically characterized. METHODS We conducted a quantitative voxel-wise meta-analysis...

Kun Xu, Bao-Lin Wu, Zi-Ru Zhao et al. · 0 citations
Open access Oct 2026

Examinations of the heterogeneity in the structural brain connectome in schizophrenia

Abstract Background Schizophrenia (SCZ) is a heterogeneous disorder characterized by widespread brain dysconnectivity, yet it remains unclear whether variable structural dysconnectivity patterns reflect biologically and clinically meaningful subtypes. Methods We recruited 105 SCZ patients and 97 healthy controls, colle...

Shu Zhao, Qian-Hui Jin, Ze-Yao Wang et al. · 0 citations
Open access Oct 2026

Validating gene-brain-behavior associations in autism: A replication study.

BACKGROUND Autism is characterized by heterogeneity in clinical characteristics, neuroimaging and genetic profiles. To elucidate the multi-level heterogeneity, Buch et al. (2023) identified biologically meaningful subgroups in Autism Brain Imaging Data Exchange (ABIDE). However, ABIDE contains non-biological sources of...

Dong-Yue Zhou, T. Mei, M. Oldehinkel et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.